ahlam1399
01-12-2017, 08:09 AM
BRIEF-Tesaro receives complete response letter for Rolapitant IV from U.S. FDA
* Tesaro receives complete response letter for Rolapitant IV from U.S. FDAhttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=lYXEZZ8hQ3w:rbTy0HbwZHk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lYXEZZ8hQ3w:rbTy0HbwZHk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=lYXEZZ8hQ3w:rbTy0HbwZHk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lYXEZZ8hQ3w:rbTy0HbwZHk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=lYXEZZ8hQ3w:rbTy0HbwZHk:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/lYXEZZ8hQ3w
* Tesaro receives complete response letter for Rolapitant IV from U.S. FDAhttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=lYXEZZ8hQ3w:rbTy0HbwZHk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lYXEZZ8hQ3w:rbTy0HbwZHk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=lYXEZZ8hQ3w:rbTy0HbwZHk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lYXEZZ8hQ3w:rbTy0HbwZHk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=lYXEZZ8hQ3w:rbTy0HbwZHk:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/lYXEZZ8hQ3w